Article
Personalized therapy on the horizon for squamous cell carcinoma of the lung.
Lung cancer (Amsterdam, Netherlands) - 1 Jun 2013
Kim Han Sang, Mitsudomi Tetsuya, Soo Ross A, Cho Byoung Chul
Abstract excerpt
Squamous cell carcinoma (SQCC) of the lung is the second-largest subtype of non-small cell lung cancer (NSCLC), causing an estimated 400,000 deaths per year worldwide. Recent developments in cancer genome sequencing technology expanded our knowledge of driver mutations, which were identified as novel candidates for targeted therapy in various cancers. Successful targeted treatments for lung adenocarcinoma,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
